"Main threat we are facing as far as viral disease is concerned, is from HIV virus. We need to find a vaccine to prevent HIV and that will happen in near future", he said at a function here.
"As far as Ebola is concerned, it is only a transient phenomenon and it will subside very soon", he told a symposium on "Emerging and re-emerging viral diseases: Developing a strategy for surveillance" in the "India International Public health Conference".
The seminar was attended by more than 1,000 delegates from India and abroad and various issues relating to public health were discussed and deliberated upon.
As many as 30 research papers were presented at the conference.
As part of the conference a seminar on "Viruses and Cancer" by Dr Robert Gallo, "Cancer Control in Kerala" by Dr M V Pillai, "Vaccine: The most successful public health" measure by Prof Dr Noel Narayanan were held.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
